...and for what it's worth, I imagine that RA capital looked at their portfolio and saw they were heavily exposed to certain areas (HepC, HepB?) and just did some re-weighting
positive signal to market? - no
major significance? - no
BLT Price at posting:
$1.12 Sentiment: Buy Disclosure: Held